New asthma drug aims to tame severe attacks
NCT ID NCT06680947
Summary
This study is testing an investigational antibody drug for adults with a specific type of severe asthma. The goal is to see if adding this drug to standard care can help people breathe better and have fewer serious asthma attacks over a year. About 225 participants will receive either the drug or a placebo to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.